Last edition
News about "Sino Biopharmaceutical"
Sino Biopharma and AstraZeneca Sign Licensing Deal for TQC3721
Sino Biopharmaceutical has signed an exclusive licensing agreement with AstraZeneca to develop, manufacture, and commercialise TQC3721, a novel PDE3/4 inhibitor for respiratory diseases.
Sino Biopharmaceutical | 09/07/2026 | By News Bureau
GSK Partners with Sino Biopharmaceutical to Accelerate Hepatitis B Therapy Launch in China
GSK and Sino Biopharmaceutical’s CTTQ have partnered to accelerate the launch of bepirovirsen in China, aiming to expand access to a potential first-in-class chronic hepatitis B therapy with functional cure potential.
Sino Biopharmaceutical | 12/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy